Van Heron Labs is a biotechnology company that utilizes genomics, bioinformatics, AI, and nanotechnology for cellular nutrition solutions, including basal media, supplements, feeds, and bioreactor additives.
The company has developed a proprietary media formulation platform, which, according to the company, can enhance any cell, tissue, or organism type within any culture or bio-manufacturing setting. Further, it allows customized optimization of key metrics, such as cell proliferation and viability, and can be used for various applications, including cellular agriculture, biologics, gene therapy, and precision fermentation. This proprietary approach claims to offer a less costly and time-intensive alternative to outdated methods of cell engineering, culture, and fueling.
Additionally, the company offers Ser-X Technology. This can be used in conjunction with its platform or as a standalone service and helps companies transition from serums like FBS to chemically defined media.
Funding and financials
In March 2024, the company raised USD 1.1 million in seed funding led by FoodLabs. The funding was earmarked for improving its technology platform and commercializing product offerings and services.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.